Strategic partnerships Neuralink is actively engaging in global clinical trials and has publicized collaboration avenues (e.g., Neko Health AB). This indicates a potential sales opportunity for CRO-like services, research partnerships, or pilot programs to support trial recruitment, data analytics, or regulatory consulting.

Clinical trial expansion With FDA Breakthrough Device designations and ongoing trials internationally, there is a demand for clinical operations support, imaging, data management, and surgical robotics integration to scale trials and improve patient screening and outcomes.

Tech stack alignment Neuralink relies on enterprise tools like Oracle Cloud, Azure AD, Jira, Grafana and other modern platforms, signaling opportunities to offer integration services, cybersecurity hardening, data pipelines, and workflow automation tailored for regulated neurotechnology development.

Healthcare market trends The company focuses on enabling brain-computer interfaces for daily-life enhancements and assistive devices, presenting sales avenues for hardware-software ecosystems, developer tools, and combined device-software solutions targeting mobility aids, communication, and autonomy.

Investment and scale Significant funding and a sizable headcount indicate readiness for scalable partnerships, manufacturing enablement, supplier onboarding, and professional services to support rapid expansion, quality systems, and international regulatory readiness.